188 related articles for article (PubMed ID: 33732288)
1. Epigenetic Regulation of the N-Terminal Truncated Isoform of Matrix Metalloproteinase-2 (NTT-MMP-2) and Its Presence in Renal and Cardiac Diseases.
Cruz JO; Silva AO; Ribeiro JM; Luizon MR; Ceron CS
Front Genet; 2021; 12():637148. PubMed ID: 33732288
[TBL] [Abstract][Full Text] [Related]
2. An intracellular matrix metalloproteinase-2 isoform induces tubular regulated necrosis: implications for acute kidney injury.
Ceron CS; Baligand C; Joshi S; Wanga S; Cowley PM; Walker JP; Song SH; Mahimkar R; Baker AJ; Raffai RL; Wang ZJ; Lovett DH
Am J Physiol Renal Physiol; 2017 Jun; 312(6):F1166-F1183. PubMed ID: 28331061
[TBL] [Abstract][Full Text] [Related]
3. Enhanced expression of two discrete isoforms of matrix metalloproteinase-2 in experimental and human diabetic nephropathy.
Kim SS; Shin N; Bae SS; Lee MY; Rhee H; Kim IY; Seong EY; Lee DW; Lee SB; Kwak IS; Lovett DH; Song SH
PLoS One; 2017; 12(2):e0171625. PubMed ID: 28178341
[TBL] [Abstract][Full Text] [Related]
4. Novel intracellular N-terminal truncated matrix metalloproteinase-2 isoform in skeletal muscle ischemia-reperfusion injury.
Joshi SK; Lee L; Lovett DH; Kang H; Kim HT; Delgado C; Liu X
J Orthop Res; 2016 Mar; 34(3):502-9. PubMed ID: 26213293
[TBL] [Abstract][Full Text] [Related]
5. N-terminal truncated intracellular matrix metalloproteinase-2 induces cardiomyocyte hypertrophy, inflammation and systolic heart failure.
Lovett DH; Mahimkar R; Raffai RL; Cape L; Zhu BQ; Jin ZQ; Baker AJ; Karliner JS
PLoS One; 2013; 8(7):e68154. PubMed ID: 23874529
[TBL] [Abstract][Full Text] [Related]
6. Two Distinct Isoforms of Matrix Metalloproteinase-2 Are Associated with Human Delayed Kidney Graft Function.
Wanga S; Ceron CS; Delgado C; Joshi SK; Spaulding K; Walker JP; Song S; Olson JL; Lovett DH
PLoS One; 2015; 10(9):e0136276. PubMed ID: 26379248
[TBL] [Abstract][Full Text] [Related]
7. A N-terminal truncated intracellular isoform of matrix metalloproteinase-2 impairs contractility of mouse myocardium.
Lovett DH; Chu C; Wang G; Ratcliffe MB; Baker AJ
Front Physiol; 2014; 5():363. PubMed ID: 25309453
[TBL] [Abstract][Full Text] [Related]
8. The two isoforms of matrix metalloproteinase- 2 have distinct renal spatial and temporal distributions in murine models of types 1 and 2 diabetes mellitus.
Kim IY; Kim SS; Lee HW; Bae SS; Ha HK; Jung ES; Lee MY; Han M; Rhee H; Seong EY; Lee DW; Lee SB; Lovett DH; Song SH
BMC Nephrol; 2018 Sep; 19(1):248. PubMed ID: 30253743
[TBL] [Abstract][Full Text] [Related]
9. A novel intracellular isoform of matrix metalloproteinase-2 induced by oxidative stress activates innate immunity.
Lovett DH; Mahimkar R; Raffai RL; Cape L; Maklashina E; Cecchini G; Karliner JS
PLoS One; 2012; 7(4):e34177. PubMed ID: 22509276
[TBL] [Abstract][Full Text] [Related]
10. The expression of two isoforms of matrix metalloproteinase-2 in aged mouse models of diabetes mellitus and chronic kidney disease.
Rhee H; Han M; Kim SS; Kim IY; Lee HW; Bae SS; Ha HK; Jung ES; Lee MY; Seong EY; Lee DW; Lee SB; Lovett DH; Song SH
Kidney Res Clin Pract; 2018 Sep; 37(3):222-229. PubMed ID: 30254846
[TBL] [Abstract][Full Text] [Related]
11. Doxorubicin induces de novo expression of N-terminal-truncated matrix metalloproteinase-2 in cardiac myocytes.
Chan BYH; Roczkowsky A; Moser N; Poirier M; Hughes BG; Ilarraza R; Schulz R
Can J Physiol Pharmacol; 2018 Dec; 96(12):1238-1245. PubMed ID: 30308129
[TBL] [Abstract][Full Text] [Related]
12. Enhanced cardiac expression of two isoforms of matrix metalloproteinase-2 in experimental diabetes mellitus.
Lee HW; Lee SJ; Lee MY; Park MW; Kim SS; Shin N; Lovett DH; Bae SS; Ahn J; Park JS; Oh JH; Choi JH; Lee HC; Cha KS; Hong TJ; Song SH
PLoS One; 2019; 14(8):e0221798. PubMed ID: 31461499
[TBL] [Abstract][Full Text] [Related]
13. Role of oxidative stress in epigenetic modification of MMP-9 promoter in the development of diabetic retinopathy.
Kowluru RA; Shan Y
Graefes Arch Clin Exp Ophthalmol; 2017 May; 255(5):955-962. PubMed ID: 28124145
[TBL] [Abstract][Full Text] [Related]
14. Renal matrix metalloproteinase activity is unaffected by experimental ischemia-reperfusion injury and matrix metalloproteinase inhibition does not alter outcome of renal function.
Ziswiler R; Daniel C; Franz E; Marti HP
Exp Nephrol; 2001; 9(2):118-24. PubMed ID: 11150860
[TBL] [Abstract][Full Text] [Related]
15. Hypothermic Machine Perfusion Reduced Inflammatory Reaction by Downregulating the Expression of Matrix Metalloproteinase 9 in a Reperfusion Model of Donation After Cardiac Death.
Fu Z; Ye Q; Zhang Y; Zhong Z; Xiong Y; Wang Y; Hu L; Wang W; Huang W; Ko DS
Artif Organs; 2016 Jun; 40(6):E102-11. PubMed ID: 26813475
[TBL] [Abstract][Full Text] [Related]
16. Crosstalk Between Histone and DNA Methylation in Regulation of Retinal Matrix Metalloproteinase-9 in Diabetes.
Duraisamy AJ; Mishra M; Kowluru RA
Invest Ophthalmol Vis Sci; 2017 Dec; 58(14):6440-6448. PubMed ID: 29261844
[TBL] [Abstract][Full Text] [Related]
17. Matrix Metalloproteinase-2 (MMP-2) Gene Deletion Enhances MMP-9 Activity, Impairs PARP-1 Degradation, and Exacerbates Hepatic Ischemia and Reperfusion Injury in Mice.
Kato H; Duarte S; Liu D; Busuttil RW; Coito AJ
PLoS One; 2015; 10(9):e0137642. PubMed ID: 26355684
[TBL] [Abstract][Full Text] [Related]
18. Mitochondria-Associated Matrix Metalloproteinases 2 and 9 in Acute Renal Pathologies.
Pevzner IB; Zorova LD; Galkin FA; Plotnikov EY; Zorov DB
Bull Exp Biol Med; 2019 Jan; 166(3):334-338. PubMed ID: 30627903
[TBL] [Abstract][Full Text] [Related]
19. Macrophage infiltration and renal damage are independent of matrix metalloproteinase 12 in the obstructed kidney.
Abraham AP; Ma FY; Mulley WR; Ozols E; Nikolic-Paterson DJ
Nephrology (Carlton); 2012 May; 17(4):322-9. PubMed ID: 22257277
[TBL] [Abstract][Full Text] [Related]
20. Identification of Candidate Genes Involved in Renal Ischemia/Reperfusion Injury.
Su M; Hu X; Lin J; Zhang L; Sun W; Zhang J; Tian Y; Qiu W
DNA Cell Biol; 2019 Mar; 38(3):256-262. PubMed ID: 30668132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
